Clinical Trial Update: A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC [Phase 2, Phase 3]

View source ↗

Summary

A prospective Phase II trial using circulating tumor DNA to guide post-operation boost therapy after adjuvant chemotherapy in triple-negative breast cancer is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: RECRUITING